Abstract
Mast cell alterations have been implicated in the pathogenesis of chronic ulcerative colitis (UC). We studied the effect of mast cell deficiency on the severity of inflammation in a murine model of colitis. Colitis was induced in mice using dextran sodium sulfate (DSS). Mast-cell-deficient mice (WBB6F1/J-W/Wv;N=17) and normal littermates (WBB6F1/J-+/+;N=17) were administered DSS 4% w/v for seven days, then water alone for one week, followed by 5% DSS for six days. Animals were sacrificed at the end of the protocol. Segments of proximal, mid-, and distal colon of each animal were processed for histopathological examination. Mortality and morbidity (diarrhea and weight loss) for each group were assessed. There was no significant difference between the two groups in either their clinical parameters (mortality and morbidity) or the severity of colitis as graded histopathologically. Our findings suggest that mast cells are not crucial for the development of DSS-induced colitis.
Similar content being viewed by others
References
Baum CA, Bhatia P, Miner PB: Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis. Dig Dis Sci 34:1462–1465, 1989
Caufield JP, Hein A, Helfgott SM, Brahn E, Dynesius-Trentham RA, Trentham DE: Intra-articular injection of arthritogenic factor causes mast cell degranulation, inflammation, fat necrosis, and synovial hyperplasia. Lab Invest 59:82, 1988
Hiatt RB, Katz L: Mast cells in inflammatory conditions of the gastrointestinal tract. Am J Gastroenterol 37:541–545, 1962
Molas GJ, Flejou JF, Potet F: Microscopic colitis, collagenous colitis, and mast cells. Dig Dis Sci 35:920–921, 1990
Nolte H, Spjeldnaes N, Kruse A, Windelborg B: Histamine release from gut mast cells from patients with inflammatory bowel diseases. Gut 32:791–794, 1990
Qureshi R, Jakschik BA: The role of mast cells in thioglycollate-induced inflammation. J Immunol 141:2090, 1988
Ranlov P, Nielson MH, Waustrupt J: Ultrastructure of the ileum in Crohn's disease: Immune lesions and mastocytosis. Scand J Gastroenterol 7:471–476, 1972
Sommers SC: Mast cells and Paneth cells in ulcerative colitis. Gastroenterology 51:841–848, 1966
Strobel S, Busuttil A, Ferguson A: Human intestinal mucosal mast cells: Expanded population in untreated celiac disease. Gut 24:222–227, 1983
Wershill BK, Murakami T, Galli SJ: Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate-13 acetate. J Immunol 140:2356, 1988
Wasserman SI: Mediators of immediate hypersensitivity. J Allergy Clin Immunol 72:101–115, 1983
Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J: Mast Cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97:575–585, 1989
Matter SE, Bhatia PS, Miner PB: Evaluation of antral mast cells in nonucler dyspepsia. Dig Dis Sci 35:1358–1363, 1990
Letourneau R, Kelly CP, Theoharides TC: Mucosal mast cell degranulation is an early event inC. difficile toxin A enteritis in rat ileum. Gastroenterol 104:A677, 1993
DeSchryver-Kecskemeti K, Williamson JR, Jakschik BA, Clouse RE, Alpers DH: Mast cell granules within endothelial cells: A possible signal in the inflammatory process? Mod Pathol 5(3):343, 1992
Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, Lichtenstein LM: Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 99:119–124, 1990
King T, Biddle W, Bhatia P, Moore J, Miner PB: Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig Dis Sci 37:490–495, 1992
Miner PB: The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis. J Invest Dermatol 96:40S-44S, 1991
Flejou JF, Grimaud JA, Molas G, Baviera E, Potet F: Collagenous colitis: Ultrastructural study and collagen immunotyping of four cases. Arch Pathol Lab Med 108:977–982, 1984
Fox CC, Moore WC, Lichtenstein: Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci 36:179–184, 1991
Goldsmith P, McGarty B, Walls AF, Church MK, Millwardsadler GH, Robertson DAF Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci 35:1409–1414, 1990
Bercovitz ZT, Somers SC: Altered inflammatory reaction in nonspecific ulcerative colitis. Arch Intern Med 117:504–510, 1966
Sarin SK, Malhotra V, Gupta SS, Karol A, Gaur SK, Anand BS: Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. Dig Dis Sci 32:363–367, 1987
Lloyd G, Green HY, Fox H, Mani V, Turnberg LA: Mast cells and immunoglobulin E in inflammatory bowel disease. Gut 16:861–866, 1975
Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaga R: A novel method in the induction of reliable experimental acute and chronic colitis in mice. Gastroenterology 98:694–702, 1990
Galli SJ, Kitamura Y: Genetically mast cell deficient W/Wv and S1/S1d mice. Their value for the analysis of the role of mast cells in biologic responsesin vivo. Am J Pathol 127:191–198 1987
Chin KW, Barrett KE: Mast cells are not essential to inflammation in murine model of colitis. Dig Dis Sci 39:513–525, 1994
Murthy SNS, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ: Treatment of dextran sulfate sodium induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 38:1722–1734, 1993
Binder V, Elsborg L, Greibe J, Hendriksen C, Lene HOJ, Jensen KB, Kristensen E, Madsen JR, Marner B, Riis P, Willumsen L: Disodium cromoglycate in the treatment of ulcerative colitis and Crohn's disease. Gut 22:55–60, 1981
Woodbury RG, Miller HR, Huntley JF, Newlands GF, Palliser AC, Wakelin D: Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in the rat. Nature 312:450–452, 1984
Barrett KE, Metcalfe DD: The mucosal mast cell and its role in gastrointestinal allergic diseases. Clin Rev Allergy 2:39–53, 1984
Taylor KB, Truelove SC, Wright R: Serologic reactions to gluten and cow's milk proteins in gastrointestinal disease. Gastroenterology 46:99–108, 1964
Galli SJ, Wershil BK, Bose R, Walker PA, Szabo S: Ethanolinduced acute gastric injury in mast cell deficient mice and congenic normal mice. Evidence that mast cells can augment the area of damage. Am J Pathol 128:131–140, 1988
Takeuchi K, Nishiwaki H, Okabe S: Cytoprotective action of mast cell stabilizers against ethanol induced gastric lesions in rats. Jpn J Pharmacol 42:297–307, 1986
Beck PL, Morris GP, Wallace JL: Reduction of ethanol induced gastric damage by sodium cromoglycate and FPL-52694. Role of leukotrienes, prostaglandins and mast cells in the protective mechanism. Can J Physiol Pharmacol 67:287–293, 1989
Goosens J, Van Reempts J, Van Wauwe JP: Cytoprotective effects of disodium cromoglycate on rat stomach mucosa. Br J Pharmacol 91:165–169, 1987
Karmeli F, Eliakim R, Okon E, Rachmilewitz D: Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology 100:1206–1216, 1991
Befus DE, Goodacre R, Dyck N, Bienenstock J: Mast cell heterogeneity in man: Histologic studies of the intestine. Int Arch Allergy Appl Immunol 76:232–236, 1985
Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM: Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity. J Immunol 139:3062–3069, 1987
Tharp MD, Kagey-Sobotka A, Fox CC, Marone G, Lichtenstein LM, Sullivan TJ: Functional heterogeneity of human mast cells from different anatomical sites:In vitro responses to morphine sulfate. J Allergy Clin Immunol 79:646–652, 1987
Gaffney PR, OLeary JJ, Doyle CT, Gaffney A, Hogan J, Smew F, Annis P: Response to heparin in patients with ulcerative colitis. Lancet 337:238–239, 1991
Ahmed T, Garrigo J, Danta I: Preventing bronchoconstriction in exercise induced asthma with inhaled heparin. N Engl J Med 29:90–95, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Minocha, A., Thomas, C. & Omar, R. Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice. Digest Dis Sci 40, 1757–1762 (1995). https://doi.org/10.1007/BF02212698
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02212698